Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP7373 in Healthy Adults
NCT01450579Phase 2Completed
- Sponsor
- UMN Pharma Inc.
- Start
- Jul 2011
- Primary completion
- Dec 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of UMN-0501, sponsored by UMN Pharma Inc.. Started Jul 2011; status: completed.
02
Drugs
UMN-0501
Beyond the preview
Go deeper on NCT01450579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01450579.